Drug intelligence / Profile preview

Shuanghe Tang

Development stage: Preclinical
Administration: Oral

Overview

Shuanghe Tang (Ssanghwa-tang, SHT) is a Yin-tonification herbal formula originating from traditional Chinese medicine, also widely used in Korea and Japan. It is composed of nine medicinal herbs. Traditionally, it is used for balancing yin and yang energies, alleviating fatigue, pain, and inflammation, and improving overall vitality. In vitro studies have shown that Shuanghe Tang inhibits the activities of human cytochrome P450 (CYP) isozymes, specifically CYP1A2 and CYP2E1. Modern research also indicates its hepatoprotective, anti-melanogenic, analgesic, and antioxidant properties. It has been studied for its potential to attenuate post-ischemic brain injury and edema in stroke models and to suppress airway inflammation.

Other names: Ssanghwa-tangSsanghwa-chaSouwato

Targets

CYP1A2 (Cytochrome P450 1A2)CYP2E1

Beyond the preview

Go deeper on Shuanghe Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuanghe Tang.

Explore the full profile